Agilent Technologies vs Scala Biodesign
Agilent Technologies vs Scala Biodesign, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Agilent Technologies is on 24/100 and Scala Biodesign on 56/100.
Where each one leads
Agilent Technologies
- domain rating: 81/100 against 23/100
- funding raised: $53B against $21.5M
Scala Biodesign
- our overall score: 56/100 against 24/100
- agent readiness: 45/100 against 40/100
At a glance
| Measure | Agilent Technologies | Scala Biodesign |
|---|---|---|
| What it is | Global leader in life sciences, diagnostics, and applied chemical markets. | Designs proteins with superior properties using computational analysis, evolutionary insights, and AI. |
| Category | Life Sciences, Diagnostics, Analytical Instruments, Laboratory Equipment | Life Sciences, Biotech, Protein, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | software | services | platform | Software |
| Founded | 1999 | 2021 |
| Headquarters | Santa Clara, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Agilent Technologies | Scala Biodesign |
|---|---|---|
| Employees | Not published | 30 |
| Headcount growthLast 12 months | Not published | +49.4% |
| Total funding | $53B | $21.5M |
| Latest round | Public | Series A |
| Valuation | $52B | Not published |
| LinkedIn followers | Not published | 5,945 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Agilent Technologies | Scala Biodesign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 24/100 | 56/100 |
| Traction | 40/100 | 52/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 17/100 | 34/100 |
| Quality | 15/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 81/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Agilent Technologies | Scala Biodesign |
|---|---|---|
| CMS | Not detected | Wix |
| Analytics | Not detected | Linkedin Insight |
| Open source | No | Yes |
Agilent Technologies vs Scala Biodesign: common questions
Which is better, Agilent Technologies or Scala Biodesign?
On our 0-100 score Scala Biodesign rates higher (56/100 against 24/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Agilent Technologies and Scala Biodesign compare on the numbers?
Agilent Technologies leads on domain rating (81/100 against 23/100), funding raised ($53B against $21.5M). Scala Biodesign leads on our overall score (56/100 against 24/100), agent readiness (45/100 against 40/100).
Read the full Agilent Technologies review and pricing or the Scala Biodesign review and pricing. You can also browse other Agilent Technologies alternatives we track.